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• INSL3/RXFP2 evolution promoted internal fertilisation and viviparity in mammals. 18 
• The INSL3 system is linked to male phenotype and horn growth. 19 
• INSL3 is an ideal monitor of fetal, pubertal and seasonal development. 20 





Although the insulin-like peptide hormone INSL3 and its cognate receptor RXFP2 (relaxin-family 24 
peptide receptor 2) have existed throughout chordate evolution, their physiological diversification 25 
appears to be linked closely with mammalian emergence and radiation. In contrast, they have been 26 
lost in birds and reptiles. Both hormone and receptor are expressed from autosomal genes which 27 
have maintained their synteny across vertebrate evolution. Whereas the INSL3 gene comprises only 28 
two exons closely linked to the JAK3 gene, RXFP2 is normally encoded by 18 exons. Both genes, 29 
however, are subject to alternative splicing to yield a variety of possibly inactive or antagonistic 30 
molecules.  In mammals, the INSL3-RXFP2 dyad has maintained a probably primitive association with 31 
gametogenesis, seen also in fish, whereby INSL3 promotes the survival, growth and differentiation of 32 
male germ cells in the testis and follicle development in the ovary. In addition, however, the 33 
INSL3/RXFP2 system has adopted a typical ‘neohormone’ profile, essential for the promotion of 34 
internal fertilisation and viviparity; fetal INSL3 is essential for the first phase of testicular descent 35 
into a scrotum, and also appears to be associated with male phenotype, in particular horn and 36 
skeletal growth. Circulating INSL3 is produced exclusively by the mature testicular Leydig cells in 37 
male mammals and acts as a potent biomarker for testis development during fetal and pubertal 38 
development as well as in ageing. As such it can be used also to monitor seasonally breeding animals 39 
as well as to investigate environmental or lifestyle conditions affecting development. Nevertheless, 40 
most information about INSL3 and RXFP2 comes from a very limited selection of species; it will be 41 
especially useful to gain further information from a more diverse range of animals, especially those 42 
whose evolution has led them to express unusual reproductive phenotypes. 43 
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1. Introduction 49 
 50 
Since the discovery of Insulin-like peptide 3 (INSL3; previously called relaxin-like factor, RLF, or 51 
Leydig insulin-like, Ley-IL) in 1993 (Adham et al., 1993) and its unique receptor, relaxin family 52 
peptide receptor 2 (RXFP2; previously called LGR8) in 2002 (Hsu et al., 2002; Kumagei et al., 2002), 53 
research on this hormone/receptor system has grown substantially. Initially envisaged as a relatively 54 
recent twig on the evolutionary tree, we now know that the origin of this system is in fact quite 55 
ancient and has been subject to very diverse evolutionary pressures, particularly in higher 56 
vertebrates. Fortunately, we now have very broad-ranging genomic data from many diverse species, 57 
which provide an important map upon which we can trace the path taken by this system in its 58 
evolution to present day species (Yegorov et al., 2014). But this map is theoretical and, in many 59 
cases, still hypothetical, since actual gene and protein expression, and certainly physiology, for many 60 
of the mapped species is mostly unknown, and what information we have is often extrapolated by 61 
comparison to a few well studied species. It is important to remember that, just because INSL3 and 62 
RXFP2 form an exclusive cognate hormone/receptor couple in humans and rodents, this does not 63 
mean that these two molecules have always co-evolved, and that they will always form the same 64 
exclusive cognate system in all species. Equally, we know very little indeed about transcriptional and 65 
translational regulation of these two genes, even in humans and rodents, and we have almost no 66 
information about putative gene promoters and their regulation for any other species, let alone 67 
whether these are physiologically functional in a similar way. The comparative endocrinology of the 68 
INSL3/RXFP2 system is still highly fragmented, with quite discrete foci around genomics, genetics 69 
and breeding, reproductive physiology in males and females, as well as isolated studies in other 70 
organs, mostly in humans or rodents. The present review has been undertaken in an attempt to 71 
integrate our understanding of this hormone/receptor system in an evolutionary and physiological 72 
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context. We have restricted this analysis to higher vertebrates where we have most physiologically 73 
relevant information and hence a degree of confidence about certain generalizations.   74 
 75 
 76 
2. The genomic atlas. 77 
 78 
Twenty years ago sequences of INSL3 homologues were only known for mammals, with similar 79 
sequences in lower vertebrates being allocated to paralogues of the human RLN3 gene. As a 80 
consequence INSL3 was thought of as a new mammalian gene (Wilkinson et al., 2005). Now, with full 81 
genomic data and corresponding synteny analysis for several hundred vertebrate and pre-vertebrate 82 
species available, we can be confident that INSL3 and its putative receptor RXFP2 were extant in the 83 
earliest vertebrates, such as cartilaginous fish, with possible ancestral genes of these even in 84 
agnathans, cephalochordates (e.g. Amphioxus), and echinoderms (Yegorov et al., 2014). INSL3 and 85 
RXFP2 presumably acquired their discrete identities, separate from the structurally related dyad of 86 
the peptide hormone relaxin (RLN) and its cognate receptor RXFP1, upon the first and second whole 87 
genome duplications (WGD1 and WGD2) which occurred about 540 million years ago at the 88 
beginning of the vertebrate radiation (Yegorov et al., 2014). In fish, there then followed a third 89 
genome duplication (WGD3) during teleost evolution, besides several local gene duplications and 90 
deletions in different lineages. This has been excellently documented by Yegerov and colleagues 91 
(Yegorov et al., 2014) and will not be discussed further here. Importantly, the ancestor of all 92 
tetrapods, exemplified by the coelacanth, indicated a single INSL3/RXFP2 dyad, though with an 93 
additional RXFP2-like gene evident in early vertebrates but not found in mammals (Yegorov et al., 94 
2014). 95 
 96 
Amphibia appear to have retained all three of these genes, whereas about 300 million years ago the 97 
ancestor of all birds and reptiles lost both INSL3 and RXFP2, though appear to have retained the 98 
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RXFP2-like gene (Yegorov et al., 2014), suggesting that this gene is not functionally correlated to the 99 
expression of INSL3. Whereas monotremes, like the platypus, retained both INSL3 and RXFP2, these 100 
lost the RXFP2-like gene; marsupials on the other hand appear to have retained all three genes (Park 101 
et al., 2008; Yegorov et al., 2014). Finally, the RXFP2-like gene was deleted completely about 120-102 
150 million years ago in the ancestor to all modern (eutherian) mammals, implying that all groups of 103 
placental mammals initially expressed a functional INSL3/RXFP2 dyad. What then happened and why 104 
is unclear, but detailed genomic analysis shows that, among the ancestral parents of the modern 105 
Afrotheria, both INSL3 and RXFP2 seem to have lost functionality and progressively introduced 106 
deletions and mutations into either or both genes (tenrec, golden mole, elephant shrew, manatee) 107 
(Sharma et al., 2018). In contrast, within the same clade, aardvarks, elephants and hyraxes appear to 108 
have retained functional sequences for INSL3 and RXFP2 (Sharma et al., 2018. However, it is 109 
important to note that these studies only assessed the protein-coding regions of both genes, and 110 
neither regulatory nor non-coding regions could be investigated, largely because very little is known 111 
about these even for humans and rodents. When genes lose functionality, this may first become 112 
manifest by mutations in non-coding regulatory sequences, and only subsequently by mutations in 113 
protein-coding domains (Ivell et al., 2000).  114 
 115 
 116 
3. Genes and gene expression. 117 
 118 
The preceding section describes the evolution of genomic sequences but cannot say anything about 119 
whether the genes are expressed as mRNA or protein, nor whether whatever is expressed is 120 
conventionally functional. There are several ways this might be achieved. Park et al (2008) 121 
synthesized the platypus INSL3 homologue based on the DNA sequence and showed that it indeed 122 
could activate the human RXFP2 receptor. Alternatively, one might analyse transcript data using RT-123 
PCR, EST libraries, or global mRNA-Seq for different tissues. This can provide structural and/or 124 
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quantitative expression data. Finally, specific antibodies can be raised against predicted unique 125 
peptide sequences and applied in western blots or immunohistochemistry, with the important 126 
caveat that antibody specificity must be very rigorously validated. Such approaches were all used in 127 
the early exploration of INSL3 and RXFP2 in a small selection of modern mammals (e.g. Ivell et al., 128 
1997; Balvers et al., 1998; Zarreh-Hoshyari-Khah et al., 1999; Ivell et al., 2003; Sagata et al., 2015). 129 
 130 
INSL3 is encoded by a relatively small gene, comprising just two exons (Fig 1). For the rat, mouse, 131 
bovine and human genes there is also some information on the functionality of the upstream 132 
promoter region (Koskimies et al., 1997; Dai et al., 2017a; Sadeghian et al., 2005; Tremblay et al., 133 
2009). This region appears to be restricted to less than 1000 nucleotides since the INSL3 gene is 134 
located very close to the 3’ end of the JAK3 gene in humans, rodents and ruminants (Koskimies et al., 135 
1997; Safford et al., 1997; Spiess et al., 199), and it is assumed that the latter sequences are unlikely 136 
to interfere with INSL3 regulation. In the species studied, within this upstream region there are three 137 
separate sites for interaction with the transcription factor SF-1, or related factors, any or all of which 138 
appear to be used at least in vitro to induce up-regulation of the gene (Koskimies et al., 1997; Dai et 139 
al., 2017a; Sadeghian et al., 2005; Tremblay et al., 2009). Since the synteny in relation to JAK3 and 140 
this region appears to be maintained in all the mammalian genomes studied, it seems likely that the 141 
regulation of the INSL3 gene promoter is similar in most species. SF-1 responsive elements, while 142 
binding the transcription SF-1 (NR5A1) or its paralogue Nur77 (NR4A1) to elicit an activation of the 143 
gene, may also mediate activation by steroid receptors in a non-classical manner (Tremblay et al., 144 
2009; Ivell et al., 2014; Dai et al., 2017a). This may explain why in some studies evidence suggests 145 
that INSL3 expression can be modulated to a small degree by steroid hormones (Tremblay et al., 146 
2009; Dai et al., 2017a). However, most studies indicate that INSL3 expression is both cell-specific 147 




Several studies have indicated that both in cell culture and in vivo the INSL3 gene product may be 150 
secreted as either the B-A-C pro-form precursor which includes the connecting C-domain or as the 151 
processed A-B heterodimer (Fig 1), where the C-peptide has been cleaved, presumably by PC1/2-152 
type proteolytic enzymes (Zarreh-Hoshyari-Khah et al., 1999; Büllesbach & Schwabe, 2002; 153 
Minagawa et al, 2012; Siqin et al., 2013). Whether or not this cleavage occurs in vivo may depend on 154 
species, cell type, and/or level of expression. For example, in the male pig evidence suggests that 155 
most circulating immunoreactive INSL3 occurs as the B-A-C pro-form (Minagawa et al., 2012), 156 
whereas in the human, the cleaved A-B heterodimer appears to be the prevailing form (Albrethsen 157 
et al., 2020a). 158 
 159 
Several studies, however, report that in addition to the conventional INSL3-encoding gene transcript, 160 
alternatively spliced transcripts can be expressed (Zarreh-Hoshyari-Khah et al., 1999; Sadeghian et 161 
al., 2005; Yang et al., 2020). Mostly, these represent peptides comprising an additional C-terminal 162 
sequence added to the B-domain, followed by a stop codon, and thus missing any of the 163 
downstream peptide sequence normally representing the C-terminus of the C-domain and the A-164 
domain (Fig 1). While in themselves lacking the structure to activate the RXFP2 receptor, a recent 165 
study suggests that they may in fact act antagonistically (Yang et al., 2020), similar to the B-chain 166 
dimer peptides that had been artificially created (Del Borgo et al., 2006; Shabanpoor et al., 2011). 167 
Such alternative splice products have been identified for rat, human and marmoset monkey (Zarreh-168 
Hoshyari-Khah et al., 1999; Sadeghian et al., 2005; Yang et al., 2020); whether they are generally 169 
expressed in other mammalian species or are expressed as peptide and are functional in vivo is not 170 
known, although immunohistochemistry using a specific antibody in the marmoset monkey suggests 171 
that such products are probably very rare (Zarreh-Hoshyari-Khah et al., 1999).   172 
 173 
RXFP2 is a G-protein-coupled receptor (GPCR) with a very large extracellular domain, which when 174 
expressed in cells by transfection, signals via adenylate cyclase and the generation of cAMP 175 
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(Kumagai et al., 2002; Heng et al., 2008). Its natural ligand INSL3, at least for those species where it 176 
has been studied, interacts first via the large LRR (leucine-rich repeat)-repeat region within the 177 
extracellular domain of the receptor (Fig 2), this complex then appears to bend downwards towards 178 
the cell membrane where then the N-terminal LDLa-domain of the receptor, as well as the A-domain 179 
of INSL3, can interact with the extracellular loops of the receptor transmembrane region (Halls et al., 180 
2015). Only then can activation and generation of cAMP occur. The LRR-region comprises 10 small 181 
LRRs, each of which is encoded by a separate exon all of which are in-frame with each other. 182 
Altogether, the RXFP2 gene in all species for which genome sequences are available (Yegorov et al., 183 
2014), comprises 18 exons (Fig 2), and appears to be highly conserved across all vertebrates. 184 
However, in the bovine, human, and rat, numerous alternatively spliced variants have been reported 185 
(Muda et al., 2005; Anand-Ivell et al., 2006; Heng et al., 2008; Dai et al., 2017b). Mostly these involve 186 
the splicing out of one or more of the LRR-encoding small exons, which nevertheless retain the 187 
reading frame, though sometimes also novel exons can be introduced (Fig 2). It is unclear at the 188 
present time whether these alternatively spliced variants are physiologically relevant. Certainly any 189 
loss of specific INSL3 binding, or altered receptor conformation is likely to affect INSL3 signalling, 190 
though it has been suggested that some functionality may be retained due to receptor dimerization 191 
and what is referred to as complementation, whereby a partially defective GPCR may be 192 
complemented and repaired by dimerising with a functional partner (Svendson et al., 2008; Kern & 193 
Bryant-Greenwood, 2009; Rivero-Müller et al., 2010). As for the ligand INSL3, so also for RXFP2, we 194 
have no information at all about the extent and functionality of any splice variants in vivo for any 195 
species (though see below). 196 
 197 
 198 




The radiation and success of modern mammals was largely due to two major changes to 201 
reproductive physiology which effectively made progeny more independent of environmental 202 
change and adversity. The first of these was lactation, providing the newborn young with a constant 203 
and reliable source of nutrition in the first days and weeks after birth. This appears to have occurred 204 
in the common ancestor to monotremes, marsupials and eutherians. The second innovation was the 205 
development of internal fertilisation and the retention of the embryo inside the mother with 206 
appropriate nutrition for the growing embryo provided by the formation of a placental interface 207 
between mother and offspring. This began in marsupials but was developed much further in 208 
eutherian mammals. Whilst the anatomical and physiological features of internal fertilisation and 209 
placentation are well known, these must be accompanied by the co-evolution of appropriate control 210 
systems manifest as specific and novel hormone-receptor relationships. This has led to the coining of 211 
the term ‘neohormones’ to describe those novel hormone systems whose development was 212 
essential to regulate this new mammalian physiology (Ivell & Bathgate, 2006; Anand-Ivell et al., 213 
2013). The molecules themselves are likely to have been pre-existing but in different roles and were 214 
co-opted and adapted specifically to regulate the special physiology needed to make retention of the 215 
embryo in the mother for as long as possible a success. Table 1 summarizes the diverse physiological 216 
and behavioural requirements to be regulated by neohormone systems, with examples of some of 217 
the hormones involved. Prominent amongst these are the INSL3/RXFP2 system, as well as the closely 218 
related relaxin (RLN)/RXFP1 system. Note, also, the involvement of the oxytocin (OXT)/OXTR system 219 
in many of these novel aspects. It may be significant too that paralogues of RLN also evolved by gene 220 
duplication along with mammalian emergence, including INSL4, INSL6, and RLN1 in humans, possibly 221 
responding to the same positive selection pressure. 222 
 223 
 224 




For internal fertilization to occur, one essential prerequisite is for the timed introduction of fertile 227 
sperm into the female oviduct at a time when the unfertilized egg is released from the ovary. To 228 
achieve this so that sperm are in the optimally primed state to achieve fertilization, it was essential 229 
to both store the sperm in the male system and to create a trigger which effectively initiated a series 230 
of biochemical activation events in the sperm upon their introduction into the female tract at the 231 
appropriate time. In most mammals this seems to have involved the evolution of exteriorised testes 232 
and the development of a scrotum (Ivell, 2007; Kleisner et al., 2010). The principal selection pressure 233 
appears to be a requirement for sperm storage at a temperature which is lower than abdominal 234 
temperature but nonetheless controlled. Although spermatogenesis occurs within the testes, the 235 
sperm are continually released and stored outside the testes in the cauda epididymis. The 236 
epididymis is a Wolffian derivative which sequentially secretes a series of highly specific products 237 
into its lumen which interact and modify the transiting sperm before these are stored in the final 238 
caudal sector, which is located at the lowest and coolest region of the scrotum at approximately 5oC 239 
below abdominal temperature. Here the sperm can be stored for up to several weeks prior to 240 
ejaculation. Upon ejaculation, the sperm are ejected from the cauda epididymis, mixed quickly with 241 
further secretions from the prostate gland, seminal vesicles and other glands, and injected into the 242 
female tract (either into the vagina in most mammals, or directly into the uterus, for example, in 243 
pigs), from where they are rapidly transported to the site of fertilization in the oviducts. The rapid 244 
changes in temperature, nutrients, electrolytes, pH, and hormonal milieu which occur upon 245 
ejaculation act as the trigger to initiate sperm capacitation and their fertilizing ability. 246 
 247 
How the scrotum evolved is unclear. But it involved the retention after sex determination of the 248 
testes in the inguinal region through the development of the gubernacular ligament linking the basal 249 
pole of the testes to the inguinal skin, later to become the scrotum, while the kidneys and other 250 
abdominal organs move away through body growth in an antero-dorsal direction. In most mammals 251 
this first phase of testicular descent occurs in the fetus during the second and third trimesters of 252 
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pregnancy.  This does not occur in females who retain the ovaries in a peri-renal position. There then 253 
follows a second phase of testicular descent whereby the testes pass through the inguinal canal and 254 
abdominal wall and enter the scrotum which develops as a vascularized skin sac on the outside of 255 
the body.  256 
 257 
Hormonally, the first phase of testicular descent is induced by the expression and secretion of large 258 
amounts of INSL3 by the Leydig cells of the fetal testes (Anand-Ivell & Ivell, 2014; Hutson et al., 259 
2015). In humans this begins at around weeks 10-12 of pregnancy, when high concentrations of 260 
INSL3 can also be detected in amniotic fluid from male fetuses only. In rodents, this first phase 261 
occurs relatively later, towards the last days of pregnancy and may continue into early postnatal life 262 
(Anand-Ivell & Ivell, 2014). This fetal INSL3 interacts with RXFP2 receptors which are induced in the 263 
gubernacular ligaments, probably involving androgen-dependent up-regulation of the RXFP2 gene 264 
(Yuan et al., 2010). In male mice, inactivation of either the INSL3 gene or that of its receptor RXFP2, 265 
leads to cryptorchidism with a failure of the first phase of testicular descent (Nef & Parada, 1999; 266 
Zimmermann et al., 1999; Bogatcheva et al., 2003). Interestingly, in female mice over-expression of 267 
INSL3 in the fetus leads to the formation of lower abdominal hernia (Feng et al., 2006), suggesting a 268 
way that the externalization of the fetal testes may have evolved via controlled induction of a hernia 269 
accompanying the retention of the testes in the inguinal region. 270 
 271 
Whilst the absence of testis descent into a scrotum is obviously the pre-mammalian situation, it is 272 
hard to identify any present-day mammals representing this primitive condition and it seems likely 273 
that both testis descent and testis retention may have occurred several times independently during 274 
mammalian evolution. Although marsupials exhibit testis descent and have a scrotum, the 275 
positioning of the scrotum anterior to the penis implies that this occurred separately from the event 276 
in placental mammals, where the scrotum is invariably posterior to the penis (Kleisner et al., 2010). 277 
The retention of the testes in the abdominal cavity (testicondy) appears to be common amongst the 278 
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Afrotheria (elephants, hyraxes, etc.), though whether this is a primitive trait is less clear. 279 
Importantly, both the genes for INSL3 and RXFP2 indicate variable levels of mutation and deletion 280 
within this clade (Sharma et al., 2018), with the signature species, the elephant, showing no such 281 
changes in spite of being primarily testicond. Although it does not exclude mutations within control 282 
regions of the genes, this does suggest that the loss of these genes within the clade is more likely to 283 
be a secondary consequence of testis retention or that, in some species more than others, the 284 
INSL3/RXFP2 dyad is required for other important physiological functions besides testis descent. 285 
Unfortunately, there is still no information on the expression of either INSL3 or its receptor RXFP2 at 286 
the mRNA or protein level for any of these species, nor about the cells or tissues where they might 287 
be expressed and hence the physiologies with which they may be involved. 288 
 289 
A scrotum is also absent in Cetacea and in other aquatic mammals. Testicondy in these species 290 
appears to be secondary, with the testes retained within the abdominal cavity (whales) or 291 
subcutaneously (seals) to provide both streamlining and to avoid excessive cooling. Interestingly in 292 
some of these species there is an additional testicular blood plexus which still allows cooler 293 
cutaneous blood to reduce gonadal temperature below core body levels (Rommel et al., 1992, 294 
1995). For all of these species, there appear to be no evident mutations within the coding regions of 295 
either INSL3 or RXFP2 (Yegorov et al., 2014), though also here we have no precise mRNA or protein 296 
expression data for any of these species.  297 
 298 
 299 
6. INSL3, horns and the skeletal axis. 300 
 301 
In the mature male mammal, where it has been measured, INSL3 circulates as a hormone in 302 
relatively high concentration (1-10 ng/ml or greater; Table 2). This is different from female mammals 303 
(see below) where concentrations in peripheral blood are either undetectable or generally <0.1 304 
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ng/ml (Table 2). It is logical therefore to find a relationship between INSL3 and skeletal physiology, 305 
particularly in species where there is a male gender bias in size or strength. In particular, INSL3 has 306 
been shown to modulate osteoblast and osteoclast physiology (Ferlin et al., 2017), and mice and/or 307 
humans with defective INSL3 or RXFP2 genes indicate a significant osteopenia or osteoporosis (Ferlin 308 
et al., 2008). This association with INSL3 or its receptor RXFP2 is most marked in the context of horn 309 
growth in ruminants. RXFP2 has been identified in several genomic studies in ruminants as a 310 
significantly associated gene locus linked to the selection of horn-related traits during 311 
domestication, including polling, whereby a normally horned breed lacks horns (Johnston et al., 312 
2011; Gautier & Naves, 2011; Allais-Bonnet et al., 2013; Wiedemar et al., 2014; Aldersey et al., 313 
2020). It was further shown that fetal horn buds in cattle express RXFP2 (Allais-Bonnet et al., 2013; 314 
Wiedemar et al., 2014). The development of horns amongst wild ungulate species is clearly linked to 315 
male reproductive behaviour and breeding privilege in the context of internal fertilisation and 316 
viviparity, thus suggesting that this role of the INSL3/RXFP2 system is fully in accord with the 317 
neohormone hypothesis (Table 1). There is still very little research being carried out on such aspects, 318 
particularly as regards expression studies and physiology. More relevant information on different 319 
species would be very welcome. 320 
 321 
 322 
7. INSL3 as a biomarker of Leydig cell functional capacity. 323 
 324 
The principal site of INSL3 synthesis in the male mammals which have been studied are the mature 325 
steroidogenic Leydig cells of the testes. Only the well differentiated Leydig cells of the fetal testes or 326 
those which develop during puberty in the adolescent animal express INSL3 mRNA and peptide. As 327 
discussed above, the expression of the transcription factor SF-1, or the related factor Nur 77, 328 
appears to be sufficient for high expression of the INSL3 gene, at least in vitro (Koskimies et al., 1997; 329 
Robert et al., 2006). These factors are expressed in several cell types, though especially the 330 
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steroidogenic Leydig cells, and probably account for the almost constitutive expression of INSL3 by 331 
these cells. Although adrenocortical cells also express SF-1, these cells do not normally express INSL3 332 
(Lefebvre et al., 2003), implying that other cell-specific factors may be involved. Unlike testosterone 333 
and the steroidogenic pathway, there is only little if any evidence for a diurnal rhythm in secretion, 334 
at least in human (Chong et al., 2015; Albrethsen et al., 2020b). Although acutely quasi-constitutive, 335 
INSL3 expression does depend on the differentiation state of the Leydig cells. Thus, immature Leydig 336 
cells as in pre-puberty or early adolescence, as well as those dedifferentiated by GnRH treatment or 337 
steroidal contraceptives indicate very reduced or negligible INSL3 expression (Ivell & Anand-Ivell, 338 
2009). Furthermore, as Leydig cells age, they also indicate a reduced differentiation state, which is 339 
manifest as a reduced expression and secretion of INSL3 (Anand-Ivell et al., 2006b). Taken together, 340 
these observations show that measuring the circulating concentration of INSL3 in peripheral blood is 341 
a very good parameter by which to assess the overall number and differentiation state of the Leydig 342 
cells (Leydig cell functional capacity) and hence their ability to make testicular steroids such as 343 
testosterone, without the technical problems associated with the large daily fluctuations found with 344 
that hormone (Ivell et al., 2014). 345 
 346 
Amongst the fields where INSL3 measurement has proved useful is in the assessment of male 347 
pubertal development, for example in cattle (Kawate et al., 2011; Anand-Ivell et al., 2019) or pigs 348 
(Minagawa et al., 2014;), and the factors which may influence this. Also, INSL3 could prove helpful in 349 
studying the suppression and recovery of testicular function associated with seasonal breeding 350 
(Hombach-Klonisch et al., 2004; Ivell et al., 2013) or possibly social dominance. For example, in non-351 
breeding Djungarian hamsters under a short-day lighting regime, INSL3 expression is almost 352 
undetectable, unlike when shifted to long days (Ivell et al., 2013). Similarly, deer show a markedly 353 
increased expression of INSL3 in the testes upon entering the breeding season (Hombach-Klonisch et 354 




The differences in INSL3 expression between different species and different breeds within species 357 
are still largely unexplored. We have developed several different well-validated assays to measure 358 
INSL3 using species-specific antisera (Ivell & Anand-Ivell, 2009; Vernunft et al., 2016; Anand-Ivell et 359 
al., 2009, 2011; Minagawa et al., 2014). Table 2 summarizes some of the observations made with 360 
these and similar homologous and heterologous assays. Firstly, because of the divergence of the 361 
INSL3 peptide sequence amongst different mammal species, while there is some cross-reaction of 362 
antibodies between some species, for others the antibodies do not cross-react. It is therefore very 363 
important that all such applications are appropriately validated. Secondly, there is substantial 364 
variation in the circulating INSL3 concentration between species, and between different breeds even 365 
within a species (Table 2). For example, whereas male ruminants indicate circulating INSL3 366 
concentrations in the adult of up to 10 ng/ml or more, for dogs the equivalent concentration is only 367 
approximately 0.2-0.4 ng/ml. Human males, for which most data are available suggest a normal 368 
adult range of between 0.5 and 2.5 ng/ml (Bay et al., 2005; Anand-Ivell et al., 2006; Albrethsen et al., 369 
2020b), declining at approximately 15% per decade with age (Anand-Ivell et al., 2006). 370 
 371 
 372 
8. INSL3 and spermatogenesis. 373 
 374 
RXFP2 expression using antibodies and/or mRNA has been identified in rodents, pigs, goats, bulls 375 
and humans within the seminiferous compartment of the testes, particularly on pre- and post-376 
meiotic germ cells, and to a lesser extent on spermatogonia, spermatids and spermatozoa 377 
(Kawamura et al., 2004; Anand-Ivell et al., 2006a; Filonzi et al., 2007; Siqin et al., 2010; Kohsaka, et 378 
al., 2013; Pitia et al., 2015, 2017). There is no expression on Sertoli cells. Since it has also been 379 
shown for pigs and rats that INSL3 from the Leydig cells of the interstitial compartment appears able 380 
to cross the blood-testis barrier and enter the seminiferous compartment in considerable quantities 381 
(Anand-Ivell et al., 2009; Minagawa et al., 2014), it is logical to assume that there may be a role for 382 
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INSL3 in relation to spermatogenesis or sperm function. Such a role has also recently been 383 
supported by studies on the ancestral INSL3 in zebrafish (Assis et al., 2016). However, in mammals, 384 
results are less clear cut. For pigs, both passive and active immunisation against INSL3 to reduce the 385 
levels of the testicular hormone leads to a negative impact on spermatogenesis, with significantly 386 
increased germ cell apoptosis (Sagata et al., 2015; Minagawa et al., 2018). In rats, intratesticular 387 
injection of an INSL3 receptor antagonist leads to a reduction of testis size probably due to marked 388 
germ cell loss (Del Borgo et al., 2006); and in humans, it was shown that men subjected to a 389 
prolonged steroidal contraceptive regimen indicated most impact of this on sperm production in 390 
those men whose residual circulating INSL3 was also lowest (Amory et al., 2007). In contrast, for 391 
mice whose RXFP2 gene expression in male germ cells was genetically prohibited, there appeared to 392 
be no effect of this on spermatogenesis (Huang et al., 2012). Such experiments need to be carefully 393 
distinguished from those where loss of INSL3 or RXFP2 function occurs genetically or in utero, and 394 
there is a consequent failure of testis descent, which itself causes multiple problems with 395 
spermatogenesis. 396 
 397 
There is some evidence to suggest that RXFP2 may also be expressed in or on free spermatozoa 398 
(Feugang et al., 2011, 2015; Pitia et al., 2017; Shokri et al., 2020), or on cells of the epididymal 399 
epithelium (Anand-Ivell et al., 2006b; Filonzi et al., 2007), from where it might be transferred to 400 
transiting or stored sperm by transcytosis of epithelial vesicles. Effects of INSL3 on ejaculated sperm 401 
function have also been shown for the human, but only at very high, supraphysiological INSL3 402 
concentrations (Shokri et al., 2020), so that a natural role in vivo must be doubted. Our own studies 403 
using human sperm indicated no effect at physiological concentrations (unpublished). Nevertheless, 404 
there does appear to be a correlation between RXFP2 expression on spermatozoa and sire fertility in 405 
bulls (Pitia et al., 2017). Regarding this point, we recently explored the effect of INSL3 on sperm 406 
fertility in pigs, and found that INSL3 might contribute not to sperm capacitation, but to sperm-407 
17 
 
oocyte interaction by stimulating the expression of adhesion molecules (Minagawa et al., 408 
unpublished). 409 
 410 
For all species, where the normal, as opposed to mutant, RXFP2 receptor has been cloned, 411 
expressed and pharmacologically tested (mouse, rat, bovine, human; Dai et al., 2017b; Halls et al., 412 
2017), the EC50 values are all in the peri-nanomolar range, with significant activation still possible at 413 
picomolar concentrations of INSL3. Such concentrations are well within the normal circulating 414 
concentration in adult male mammals (Table 2) and likely to be physiologically significant also for 415 
female mammals, at least locally within tissues, if not systemically. An in vitro requirement for much 416 
higher INSL3 concentration in order to see a physiological response is therefore likely to be 417 
artefactual or through a less specific mechanism. 418 
 419 
 420 
9. INSL3 and female reproductive physiology. 421 
 422 
In the female mammal, the ontogenetically equivalent cells to the Leydig cells are the steroidogenic 423 
theca interna cells of the mature ovarian follicle. These are the vascularized layer of cells 424 
encompassing the antral follicles following their selection under the influence of the gonadotropins 425 
LH and FSH to become the growing follicles of the estrous (menstrual) cycle, one or more of which 426 
will release a fertile oocyte after the LH surge. In most species, only the theca cells of healthy 427 
growing antral follicles express INSL3, and only within the follicular phase of the estrous cycle (Ivell & 428 
Anand-Ivell, 2018). This expression appears to be quite consistent amongst those mammalian 429 
species assessed, including monkey, human, mouse, and cow (Balvers et al., 1998; Irving-Rodgers et 430 
al., 2002; Hanna et al., 2011; Anand-Ivell et al., 2013; Satchell et al, 2013). In the rat, pre-antral 431 
follicles also express INSL3 (Xue et al., 2014). No other organ or cell type in the non-pregnant female 432 
appears to secrete INSL3 at a level able to influence the peripheral concentration. Consequently, it 433 
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was shown for cows and women that measurement in the circulation of INSL3 deriving from such 434 
follicles reflects their growth (Satchell et al., 2013; Anand-Ivell et al., 2013); less healthy or atretic 435 
follicles immunohistochemically fail to show any INSL3 (Irving-Rodgers et al., 2002). Although 436 
corpora lutea which result from follicles following ovulation also appear to express INSL3 mRNA 437 
(Balvers et al., 1998; Bathgate et al., 1999; Hanna et al., 2011), it is still unclear whether these tissues 438 
are able to secrete INSL3 peptide into the bloodstream. 439 
 440 
As in the male gonad, also within the ovary, the INSL3 receptor RXFP2 is found both on the INSL3-441 
producing steroidogenic theca cells, as well as on oocytes (Kawamura et al., 2004; Xue et al., 2014; 442 
Dai et al., 2017b). Recently, we have shown for the bovine that the local theca cell INSL3-RXFP2 443 
system is essential for the adequate production of the androstenedione precursor required by the 444 
inner granulosa cells for the synthesis of estrogens (Dai et al., 2017a; Ivell & Anand-Ivell, 2018). The 445 
role of RXFP2 on the oocyte, shown for the cow, as well as in rodents and monkeys (Kawamura et al., 446 
2004; Xue et al., 2014; Dai et al., 2017b), is still unclear. One early study in rats suggests a role in the 447 
Ca2+-signalling mechanisms surrounding oocyte maturation and ovulation (Kawamura et al., 2004). 448 
Inactivation of the INSL3 gene in mice leads to reduced ovulations and smaller litter size (Nef & 449 
Parada, 1999; Spanel-Borowski et al., 2001), emphasizing the importance of this system in follicle 450 
development and physiology.  451 
 452 
When a pregnant female mammal is carrying a male fetus, then a further source of INSL3 is 453 
introduced. Namely, male but not female fetuses express large amounts of INSL3 from the fetal 454 
testes, whose purpose is to promote the first transabdominal phase of testicular descent (see 455 
above). This fetal INSL3 can not only be detected in fetal blood and in amniotic or allantoic fluids 456 
(pig, rat, human; Anand-Ivell et al., 2008; Anand-Ivell & Ivell, 2014; Vernunft et al., 2016), but is also 457 
measurable in extra-fetal fluids, such as maternal blood (bovine; Anand-Ivell et al., 2011), and can 458 
even transfer from male to female fetuses within the uterus (pigs; Vernunft et al., 2016). It is still 459 
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unclear what role this fetal INSL3 may have outside the fetus, but it evidently represents a fetal sex-460 
specific hormone capable of communicating with the placenta and maternal tissues, as well as with 461 
female fetuses in multiparous species, and may underlie some of the biased physiology specifically 462 
associated with male fetal gender. That female fetuses in multiparous species mostly show no 463 
evidence of gonadal dislocation is of course due to the lack of androgen-dependent expression of 464 
the RXFP2 receptor in the ligaments attaching the ovary to the body wall. However, very few 465 




10. Other roles for the INSL3/RXFP2 system 470 
 471 
For a very limited number of species, there is also evidence for local INSL3/RXFP2 systems operating 472 
in other tissues and organs. For example, in humans and mice both INSL3 and its receptor are found 473 
associated with the corneal epithelium of the eye and linked to the lacrimal apparatus, and in vitro 474 
INSL3 appears to promote corneal growth and repair (Hampel et al., 2013). Both INSL3 and RXFP2 475 
are also expressed by epithelial cells within human thyroid cancer, though apparently not in healthy 476 
tissue, and in vitro assays suggest an effect on cancer cell differentiation, growth, and angiogenesis 477 
(Hombach-Klonisch et al., 2010). 478 
 479 
In the rat, RXFP2 appears to be expressed quite moderately in the kidney, particularly within the 480 
mesangial cells of the Bowman’s capsules; and in vitro INSL3 is able to modulate the growth and 481 
differentiation of these cells (Fu et al., 2006). It is to be noted that an altered electrolyte balance is 482 
listed as one of the phenotypic traits recorded for RXFP2-deficient mice (http://www. 483 
informatics.jax.org/humandisease.shtml), suggesting that INSL3 may have a physiological role in 484 




Finally, it is well established that, again in the rat, there is noted RXFP2 expression particularly within 487 
the thalamic region of the forebrain (Sedaghat et al., 2008), with suggested links to sensorimotor 488 
function.  However, except for the bovine hypothalamus (Bathgate et al., 1996), for no other 489 
mammal, including the rat, is there any evidence for a local synthesis of INSL3 within the brain, and 490 
whether or not INSL3 can cross the blood-brain barrier from the general circulation is still unclear. 491 
 492 
 493 
11. Synthesis. 494 
 495 
The receptor RXFP2 and its unique cognate ligand INSL3 form a paracrine and endocrine dyad, 496 
largely conserved across mammals. Where RXFP2 has been analysed in different mammalian 497 
species, there is no evidence for any other ligand being able to interact with the receptor at 498 
physiological concentrations. The related hormone relaxin can only activate RXFP2 at greatly 499 
supraphysiological concentration, thus any reference of this receptor being an alternative relaxin 500 
receptor is a misnomer. The INSL3/RXFP2 dyad or its ancestor is represented in the genomes of 501 
some of the earliest vertebrate orders, including teleosts, where it is linked specifically to 502 
spermatogenesis with INSL3 expression uniquely in Leydig cells (Assis et al., 2016). Thus, both the 503 
expression of INSL3 in mammalian Leydig cells as well as its role in modulating spermatogenesis may 504 
be considered primitive. The dyad was lost in all reptiles and birds but maintained in some form or 505 
other in all mammalian groups, including monotremes and marsupials, as well as in Amphibea. The 506 
successful radiation of mammals was dependent on the evolution of viviparity and internal 507 
fertilization, which demanded the co-evolution of novel regulatory systems, referred to as 508 
neohormones. The INSL3/RXFP2 dyad was evidently co-opted to promote and support the new 509 
physiology, leading across male mammals to its novel roles in testicular descent, and probably bone 510 
strength and horn formation. Our knowledge of the role played by INSL3 and RXFP2 in these novel 511 
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physiologies is still limited to only a few common species. Whether the important role of INSL3 and 512 
RXFP2 in female physiology is primitive or also a reflection of a neohormone role is unclear, largely 513 
because there is so little comparative data. Particularly amongst the Afrotheria (elephants, 514 
manatees, hyraxes) which exhibit varying degree of testicondy, and indicate in some species 515 
deletions and inactivation of the INSL3 and RXFP2 genes, there is a need to gather more detailed 516 
expression data at both mRNA and protein levels, besides functional information. Moreover, we 517 
need to understand better the reasons for the diversity of expression levels evident in different 518 
species of mammals, or in different breeds within a species. Finally, INSL3 is proving to be a valuable 519 
biomarker to monitor development in the fetus, during puberty and in ageing, under normal healthy 520 
conditions, as well as following environmental insults, or changes in feeding. However, such 521 
applications are limited to a few species only; it would be helpful to extend such knowledge to 522 
encompass a wider range of species, including those under threat. 523 
 524 
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Legends to Figures 850 
 851 
Figure 1 852 
Biosynthesis of rat Insl3. A. Location and synteny of the Insl3 gene on chromosome 16p14, 853 
indicating the close juxtaposition to the Jak3 gene. B. Structure of the Insl3 gene, indicating exons 1 854 
and 2, as well as additional exons 1a determined by RT-PCR (Sadeghian et al., 2005) and 1b predicted 855 
from the genomic sequence. C. The normal prepro-Insl3 precursor protein which, upon correct 856 
processing and folding as in D, can after removal of the signal peptide (SP) and cleavage of the C 857 
(connecting) peptide give rise to the secreted functional heterodimer, E. In the event that additional 858 
exon 1a is used, then the B-domain is extended followed by a Stop codon to yield an abbreviated 859 
peptide which may be a putative antagonist. If exon 1b is used, the reading-frame is maintained to 860 
yield a putative precursor with a 22 amino acid longer C-domain (Genbank XP_006252882). 861 
 862 
Figure 2 863 
Biosynthesis of bovine RXFP2. A. Location and synteny of the RXFP2 gene on bovine chromosome 864 
12. B. Composition and alternative splicing of the bovine RXFP2 gene, normally comprising 18 exons. 865 
Alternative splicing can add up to two additional exons (exons 5a and 11a) or may lead to loss of 866 
exons 13 and/or 15 in the illustrated examples, based on sequenced RT-PCR products or EST 867 
fragments (Dai et al., 2017b). The numbers below the genomic structure indicate the positions of 868 
PCR primers used for multiple RT-PCR analysis (Dai et al., 2017b). C. RXFP2 precursor protein 869 
indicating signal peptide (SP) and the key peptide domains (LDLa, low density lipoprotein a; LRR, 870 
leucine-rich repeat; hinge domain; 7TM (7-transmembrane) domain; and C-terminal intracellular 871 
signaling domain). D. Folded structure of the mature RXFP2 protein, indicating the relative locations 872 
of the various peptide domains and their specific interactions (double-headed arrows) with the 873 





Legends to Tables 877 
 878 
Table 1 879 
Reproductive physiology and behaviour acquired with mammalian emergence and regulated by 880 
neohormone systems. 881 
RLN, ovarian relaxin; OXT, oxytocin; INSL3, insulin-like peptide 3; hCG, human chorionic 882 
gonadotropin; IFN, interferon tau; TGF, transforming growth factor beta; PGF2, prostaglandin 883 
F2apha; PRL, prolactin; and their respective receptors. ? , not known. 884 
 885 
Table 2 886 
Circulating INSL3 concentration in diverse mammals. 887 
INSL3 concentration is given as mean + SD, except where indicated. *median and 95% confidence 888 
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Reproductive physiology and behaviour acquired with mammalian emergence 
and regulated by neohormone systems 
 
Biological feature Neohormone 
candidates 
Receptors 
   
Viviparity and uterine accommodation 
of the embryo (placentation) 
RLN RXFP1 
Internal fertilization and its coordination ? ? 
Appropriate male and female sexual 
behaviour 
OXT, INSL3 OXTR, RXFP2 
Maternal recognition of pregnancy hCG, IFN LHCGR, IFNR1 
Adjustment of cardiovascular function, 
electrolyte and fluid balance in 
pregnancy 
RLN RXFP1 
Adjustment of maternal immune 
tolerance to accommodate genetically 
different sperm and embryo 
TGFRLN TGFBR, RXFP1 
Thermoregulation and a constant core 
temperature 
? ? 
Regulation of the birth process, 






Perinatal analgesia ? ? 




Appropriate maternal behaviour OXT OXTR 
Scrotal testes, testicular descent, and 
reduced scrotal temperature 
INSL3 RXFP2 
Post-testicular sperm maturation, 
storage and capacitation as an 
adaptation to internal fertilization 
? ? 
Post-reproductive survival to provide 





Circulating INSL3 concentration in diverse mammals 
 
Species Breed/ Condition INSL3 (ng/ml) References 
    
Human young men (35-44 yr.) 
young men (19-40 yr.) 
1.29 + 0.47 
1.3 (0.9-2.7)* 
Anand-Ivell et al., 2006b 
Albrethsen et al., 2020a 
 old men (75-80 yr.) 0.79 + 0.39 Anand-Ivell et al., 2006b 
 adult women (30-38 yr.) 0.08 + 0.01 Anand-Ivell et al., 2013 
    
Macaque adult male 0.44 + 0.13 Hanna et al., 2010 
 adult female 0.12 + 0.01 Hanna et al., 2010 
    
Rat Sprague-Dawley    
 adult male (3 mo.) 2.81 + 0.27 Anand-Ivell et al., 2009 
 old male (24 mo.) 0.94 + 0.03 Anand-Ivell et al., 2009 
 adult female (3 mo.) 0.08 + 0.03 Anand-Ivell et al., 2009 
 Wistar   
 adult male (3 mo.) 1.51 + 0.09 Anand-Ivell et al., 2009 
 old male (24 mo.) 0.76 + 0.21 Anand-Ivell et al., 2009 
    
Mouse CBA male (2 mo.) 0.78 + 0.03 Anand-Ivell et al., 2009 
 CBA female (2 mo.) 0.05 + 0.01 Anand-Ivell et al., 2009 
    
Pig Duroc adult male 12.7 + 1.86 Minagawa et al., 2014 
 Landrace adult female 0.18 + 0.02 Vernunft et al., 2016 
    
Bovine Japanese Black adult 
male (18-24 mo.) 
7-8, 5-7 ** Hannan et al., 2015 
Weerakoon et al., 2018 
 Holstein-Friesen adult 
male (8-12 mo.) 
5.1 + 1.8 Anand-Ivell et al., 2019 
 Holstein-Friesen adult 
female  
0.18 + 0.01 Anand-Ivell et al., 2011 
    
Sheep Merino adult female 0.10 + 0.01 Anand-Ivell et al., 2011 
    
Goat Shiba adult male 25 + 7 Hannan et al., 2017 
    
Horse Adult intact male 19.9 + 17.7 Tsogtgerel et al., 2020 
    
Dog diverse breeds  
adult male 
0.49 + 0.36 
0.29 + 0.09 
Pathirana et al., 2012 
Anand-Ivell (unpublished) 
 
